Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Studying Macrophage-Epithelial Cell Interactions in Salivary Gland Regeneration After Injury
Published on: November 17, 2023
Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis
Natacha Ipseiz1, Carina Scholtysek1, Stephan Culemann1
1Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nürnberg, Erlangen, Germany; Nikolaus Fiebiger Center of Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.
Abstract:
Adopted orphan nuclear receptors, such as peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs), have emerged as key regulators of inflammation and immunity and likewise control skeletal homeostasis. These properties render them attractive targets for the therapy of various inflammatory and autoimmune diseases affecting the musculoskeletal system. This review summarises the current knowledge on the role of these families of receptors during innate and adaptive immunity as well as during the control of bone turnover and discuss the potential use of targeting these molecules during the treatment of chronic diseases such as osteoarthritis, rheumatoid arthritis and osteoporosis.
Insights
Adopted orphan nuclear receptors, like PPARs and LXRs, regulate inflammation, immunity, and bone health. Targeting these receptors offers potential therapies for musculoskeletal diseases such as osteoarthritis, rheumatoid arthritis, and osteoporosis.
Area of Science:
- Endocrinology and immunology
- Skeletal biology
Background:
- Adopted orphan nuclear receptors, including peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs), are crucial for regulating inflammatory and immune responses.
- These receptors also play a significant role in maintaining skeletal homeostasis.
- Their dual function makes them promising therapeutic targets for musculoskeletal conditions.
Purpose of the Study:
- To review the current understanding of PPARs and LXRs in innate and adaptive immunity.
- To summarize their role in bone turnover.
- To discuss the therapeutic potential of targeting these receptors for chronic musculoskeletal diseases.
Main Methods:
- Literature review of existing research on adopted orphan nuclear receptors.
- Analysis of studies focusing on PPARs and LXRs in immune regulation.
- Examination of research on their impact on bone metabolism.
Main Results:
- PPARs and LXRs are integral to both innate and adaptive immune pathways.
- These receptors significantly influence bone remodeling processes.
- Evidence suggests their involvement in the pathogenesis of inflammatory bone diseases.
Conclusions:
- Adopted orphan nuclear receptors are key modulators of immunity and skeletal homeostasis.
- Targeting PPARs and LXRs presents a viable therapeutic strategy for inflammatory and autoimmune diseases of the musculoskeletal system.
- Further research into these receptors could lead to novel treatments for osteoarthritis, rheumatoid arthritis, and osteoporosis.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction
Inflammation
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Regulation of Hematopoietic Stem Cells

